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Psychological interventions for depression in people with multiple sclerosis 
Abstract 
A systematic review was conducted to investigate the effectiveness of published trials that 
used psychological interventions to decrease depression in people with multiple sclerosis. 
A search of electronic databases (PsycARTICLES, Medline, CINAHL and Science Direct) 
was conducted as well as hand searching the reference sections of relevant literature and 
reviews. A final total of 11 studies were included, using a range of methods e.g. cognitive 
behaviour therapy (n = 7), mindfulness based stress reduction (n = 1), a general chronic 
illness group (n = 1), motivational interviewing (n = 1) and relaxation (n = 1). Psychological 
interventions such as cognitive behaviour therapy, mindfulness-based stress reduction and 
motivational interviewing can have a beneficial effect on the symptoms of depression in 
people with MS; however more rigorous research needs to be conducted in this area.  The 
results highlight the need for further research into the less common types of psychological 




Multiple sclerosis (MS) is a neurological condition which affects the central nervous 
system. It can lead to a large variety of distressing symptoms, such as fatigue, tremor, 
cognitive impairment, vision and balance problems, bladder issues and weakness (World 
Health Organisation, 2008).  
Depression is the most common type of psychological distress present in people with 
MS (Sa, 2008). Estimates of the prevalence of depression can vary, however it appears to be 




around 50% (Benito-León, Manuel Morales, Rivera-Navarro, & Mitchell, 2003). Such high 
figures have been attributed to a wide variety of issues; regarding the illness itself, the 
unpredictable nature of the disease progression, the lack of a known cure, as well as the wide 
range of often unpleasant symptoms often present in the illness (Rigby, Thornton, & Young, 
2008). 
Because medication for depression is not always appropriate (Forman & Lincoln, 
2010), a sizeable proportion of the research dedicated to depression in people with MS has 
had a psychological emphasis. A Cochrane review (Thomas, Thomas, Hillier, Galvin, & 
Baker, 2006)
 
looked at the efficacy of psychological interventions for depression and found 
that CBT could be beneficial in treating depression in this population, however were unable 
to draw definite conclusions. In another review, Hind et al. (2014) found CBT to provide 
modest benefits for depression in people with MS.  However, CBT does not always work for 
everyone, and thus other psychological interventions should be compared to assess which of 
these various options appear to be the most effective for people with MS (Mohr et al., 2001).   
The aim of this current review therefore is to build on recent appraisal of the 
literature, but to also include other types of psychological intervention.  
Method 
Inclusion and exclusion criteria 
The following inclusion criteria were identified: the report was published in English 
and published in a peer-reviewed journal. The study had to be quantitative in design and 
analysis, and had to have a significant psychological element. Participants had to be 18 years 
old or over. Only randomised controlled trials (RCTs) were considered for review. Papers 




were excluded if participants in the study were family members or carers reporting on the 
experience of the person living with MS, or if the intervention did not measure depression.  
Search strategy 
Relevant papers were identified by searching Medline, PsycArticles, CINAHL, Web 
of Science and Science Direct databases in April 2014. The databases were searched from 
2004-2014, giving a date range of just over 10 years. The lead author can be contacted for a 
comprehensive list of search terms used as well as the full search strategy employed. The 
search returned a total of 2687 studies from all databases. The journal article titles were then 
read as well as abstracts unless it was immediately clear that the article was irrelevant to the 
review. This left a possible 51 articles for inclusion. The remaining articles were then read in 
more depth, applying the inclusion and exclusion criteria, to leave a final 11 studies. 
Results 
After applying the inclusion and exclusion criteria, a total of 11 studies were deemed suitable 
for inclusion in the review (Table 1). 
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Depression: BDI; Stress: 
PSS; HLC: HLC; Anxiety: 
STAI; Symptoms of MS: 
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Chronic Disease Self-Management 
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16, weekly, 50m sessions of  
telephone CBT course. 
 
 
8, weekly, 25-50m sessions of  
MS specific computerised CBT plus 
3 phone support sessions 
 
 
3, 90m cognitive behavioural group  
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BDI: Beck Depression Inventory; BDI-II: Beck Depression Inventory Second Edition; CBT: Cognitive Behaviour Therapy; CDSMC : Chronic Disease Self-
Management Course; CES-D: Centre for Epidemiologic Studies Depression Scale; DRI: Dispositional Resilience Index; EDSS: Expanded Disability Status 
Scale; FS: Fatigue Scale; GAD: Generalised Anxiety Disorder; GHQ-12: General Health Questionnaire (12 point scale); HADS: Hospital Anxiety and 




Depression Scale; GNDS: Guy’s Neurological Disability Scale; HAM-D: Hamilton Depression Rating Scale; HAQUAMS: Hamburg Quality of Life 
Questionnaire in Multiple Sclerosis; HLC: Health Locus of Control; HRQOL: Health Related Quality of Life; IMS: Identity Motives Scale; LS-ES: Liverpool 
Self-Efficacy Scale; MBSR: Mindfulness-based Stress Reduction; MFIS: Modified Fatigue Impact Scale; MI: Motivational Interviewing; MSIS-29: Multiple 
Sclerosis Impact Scale; MSQOL-59- Multiple Sclerosis Quality of Life; MSSES: Multiple Sclerosis Self-efficacy Scale; PANAS: Positive and Negative 
Affect Scale; PHQ-9: Patient Health Questionnaire; PMR: Progressive Muscle Relaxation; PQOLC: Profile of Health Related Quality of Life; PSS: Perceived 
Stress Scale; QOL: Quality of Life; RB: Relaxation breathing; SCID: Structured Clinical Interview for DSM Disorders; SCL-20: The Hopkins Symptoms 
Checklist; SEFT: Supportive Emotion-focused therapy; SESA: Scale for the Evaluation of Self-Acceptance; SMSE: SF-36: SF-36; Medical Outcome Study 
Short Form 36; SPSI-R: Social Problem Solving Inventory Revised; STAI: Spielberger Trait Anxiety Inventory; TAU: Treatment as Usual; VAS: Visual 
Analogue Scales. 





The studies were conducted in the UK (n = 6), USA (n = 2), Greece (n = 1), Italy (n = 
1), Switzerland (n = 1). Of the 11 RCTs included in this review, three were pilot RCTs. Only 
three studies reported using diagnostic criteria for MS during recruitment.  The participant 
numbers ranged from 24 (Cooper et al., 2011) to 216 (Barlow, Turner, Edwards, & Gilchrist, 
2009).  
Participant characteristics 
1175 participants took part in the 11 studies; the mean age of participants, where 
reported, was 46.81 years (N = 1072). The mean time that participants had lived with MS was 
10.47 years, with a range of seven years (Artemiadis et al, 2012) to 18.8 years (Mohr et al., 
2005).  
Intervention characteristics 
The studies used a variety of psychological interventions: telephone based CBT 
(Mohr et al., 2005), group CBT (Forman & Lincoln, 2010; Graziano et al., 2014; Lincoln et 
al., Rigby et al., 2008) online CBT (Cooper et al., 2011; Moss-Morris et al., 2012), 
Mindfulness Based Stress Reduction (Grossman et al., 2010), a support and psycho education 
group for people with chronic illness (Barlow et al., 2009), motivational interviewing 
(Bombardier et al., 2013) and relaxation (Artemiadis et al., 2012). Only four of the trials had 
MS specific components in the interventions that were delivered (Forman & Lincoln, 2010; 
Graziano et al., 2014; Lincoln et al., 2011; Moss-Morris et al., 2012). One study had group 
members who were comprised of people with a range of other chronic illnesses (Barlow et 
al., 2009).  
Quality Appraisal 




Using the QATQSD (Effective Public Health Practice Project 1998), only three of the 
11 studies were given a global rating of ‘Strong’ (Grossman et al., 2010; Lincoln et al., 2011; 
Mohr et al. 2005), two were ‘Moderate’ (Bombardier et al., 2013; Rigby et al., 2008), and the 
remaining six were classed as ‘Weak’ study design. None of the studies adequately reported 
both whether the participants were fully aware of the research question, and whether outcome 
assessors were blinded to what arm the participants were assigned to. This meant that none of 
the studies reviewed here could be given a ‘Strong’ rating in the ‘blinding’ category of the 
tool.   
Outcomes  
One study did not provide detailed inferential statistics (Cooper et al., 2011) however 
reported a drop in depression score on the BDI to 18 for the active arm compared to 24.1 for 
the treatment as usual (TAU) control group, which is still above clinical significance. Four 
studies did not report statistically significant differences in reduction of depression between 
intervention and control groups (Artemiadis et al., 2012; Barlow et al., 2009; Graziano et al., 
2014; Rigby et al., 2008) with the remaining six reporting statistically significant results. Of 
the different types of intervention, the general chronic illness support group, relaxation CDs, 
and three of the eight CBT interventions did not provide significant reductions in depressive 
symptoms. Four of the eight CBT interventions reported statistically significant results 
(Forman & Lincoln, 2010; Lincoln et al., 2011; Moss-Morris et al., 2012), as did three of the 
six group therapy interventions (Forman & Lincoln, 2010; Grossman et al., 2010; Lincoln et 
al., 2011). Of those studies which reported effect sizes, one reported a large effect size 
regarding change in scores on the depression measures used from baseline to post treatment 
in the treatment group (Bombardier et al., 2013), two reported a medium effect size 
(Artemiadis et al., 2012; Grossman et al., 2010)
 
and one a small effect size (Barlow et al, 




2009). The medium effect size was reduced to a small effect size at follow up in one study 
(Grossman et al. 2010).  
Discussion 
 This review indicates that seven of the 11 studies reported significant reductions in 
depression in the treatment arm compared to the control. In the most commonly used 
intervention (CBT), 62.5% of the studies reported reductions. Of the six studies that reported 
effect sizes, 67% reported a medium effect size in reduction of depression scores compared to 
the control group. The most commonly used active treatment was CBT, which was used in 
seven of the 11 studies. Of these studies, five reported significant reductions in depression 
post treatment.  
Methodological issues 
Many limitations in the studies were evident. In the majority of studies, the 
comparison group was treatment as usual, or a wait-list control group and so the specificity of 
the treatment arm was not being tested. This runs the risk of performance bias as there may 
be many effects of attending a group or completing a programme such as those reviewed 
here. A comparison intervention in which the control group is also receiving a similar amount 
of attention or social support from other group members would be far more advantageous. 
Limitations of the study 
Only 11 suitable studies were retrieved during the search which indicates that there is 
a lack of research internationally on depression in people with MS. This is concerning 
particularly given the inconsistent findings regarding the effectiveness of CBT interventions, 
and also that there is such a wide range of other treatment options that need to be tested in 
controlled studies. 




Need for further research. 
Future research regarding the use of online CBT courses for the reduction of 
depressive symptoms should take into account the difficulties reported here, as all the studies 
reported low compliance rates and issues with participants completing the intervention due to 
lack of flexibility.  
Current UK National Institute for Health and Care Excellence (NICE, 2009) 
guidelines for people with mild to moderate depression and a chronic physical illness 
recommend group based peer support such as that conducted by Barlow et al (2009), 
structured physical activity, computerised CBT (Cooper et al., 2011) or guided CBT based 
self-help. For those with moderate depression, group CBT, individual CBT or behavioural 
couples therapy are recommended if the individual has a partner and if their physical and 
psychological difficulties are affecting the relationship. It is interesting to note that of this 
latter recommendation that no such study was identified during this review. Some of the 
study designs reported here such as MBSR (Grossman et al., 2010), and telephone CBT 
(Mohr et al., 2005) yielded promising results regarding reducing depression, however are not 
currently included in these guidelines. Further research is therefore needed in these areas to 
strengthen the evidence base regarding these interventions as they may prove to be useful 
methods for treating depression in those with MS. 
Conclusion 
Treating depression in people with MS by using psychological interventions can in 
some circumstances significantly reduce symptoms when compared to control groups, 
however there are several methodological limitations in the studies reviewed here. More 
research needs to be done to clarify the conflicting results. In particular, there is a need for 
more RCTs that have an active control, as well as studies with participants that are selected 




from a more representative population in order to make the results of the study more easily 
generalisable to the wider population who are living with MS. Specifically, interventions 
using CBT, MBSR-based treatment components, and increased physical activity through 
Motivational Interviewing techniques appear to significantly reduce depression in this 
population, however more research needs to be conducted and by using more rigorous 
methodological study designs and by selecting participants by using more representative 
methods.  
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